ADENOSCAN (nda020059)- (60MG/20ML (3MG/ML),90MG/30ML (3MG/ML))

Generic Name	ADENOSINE	Innovator	ASTELLAS
Dosage	60MG/20ML (3MG/ML),90MG/30ML (3MG/ML)
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2015-Mar-24	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Intravenous Adenoscan is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
7	0	7

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
60MG/20ML (3MG/ML)	**	**	-	-	-
90MG/30ML (3MG/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	7

Manufacturing Details of ADENOSCAN